1. Home
  2. EVO vs COUR Comparison

EVO vs COUR Comparison

Compare EVO & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • COUR
  • Stock Information
  • Founded
  • EVO 1993
  • COUR 2012
  • Country
  • EVO Germany
  • COUR United States
  • Employees
  • EVO N/A
  • COUR N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • COUR Computer Software: Prepackaged Software
  • Sector
  • EVO Health Care
  • COUR Technology
  • Exchange
  • EVO Nasdaq
  • COUR Nasdaq
  • Market Cap
  • EVO 1.6B
  • COUR 1.3B
  • IPO Year
  • EVO 2021
  • COUR 2021
  • Fundamental
  • Price
  • EVO $4.44
  • COUR $8.04
  • Analyst Decision
  • EVO Buy
  • COUR Buy
  • Analyst Count
  • EVO 2
  • COUR 14
  • Target Price
  • EVO $5.90
  • COUR $10.77
  • AVG Volume (30 Days)
  • EVO 46.1K
  • COUR 2.2M
  • Earning Date
  • EVO 11-06-2024
  • COUR 01-30-2025
  • Dividend Yield
  • EVO N/A
  • COUR N/A
  • EPS Growth
  • EVO N/A
  • COUR N/A
  • EPS
  • EVO N/A
  • COUR N/A
  • Revenue
  • EVO $866,665,179.00
  • COUR $694,674,000.00
  • Revenue This Year
  • EVO $3.84
  • COUR $5.97
  • Revenue Next Year
  • EVO $10.94
  • COUR $5.31
  • P/E Ratio
  • EVO N/A
  • COUR N/A
  • Revenue Growth
  • EVO N/A
  • COUR 9.27
  • 52 Week Low
  • EVO $2.85
  • COUR $6.29
  • 52 Week High
  • EVO $7.98
  • COUR $16.74
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.82
  • COUR 45.91
  • Support Level
  • EVO $4.40
  • COUR $7.78
  • Resistance Level
  • EVO $4.49
  • COUR $9.02
  • Average True Range (ATR)
  • EVO 0.10
  • COUR 0.37
  • MACD
  • EVO -0.00
  • COUR 0.01
  • Stochastic Oscillator
  • EVO 38.46
  • COUR 41.23

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: